112 related articles for article (PubMed ID: 35636632)
1. A novel variant of DeSanto-Shinawi Syndrome with joint manifestations.
Branco J; Amorim M; Conde M
Eur J Med Genet; 2022 Jul; 65(7):104534. PubMed ID: 35636632
[TBL] [Abstract][Full Text] [Related]
2. Patients with DeSanto-Shinawi syndrome: Further extension of phenotype from Italy.
Pasquali D; Torella A; Grandone A; Luongo C; Morleo M; Peduto C; di Fraia R; Selvaggio LD; Allosso F; Accardo G; Zanobio MT; Maitz S; Mariani M; Selicorni A; Banfi S; Nigro V;
Am J Med Genet A; 2023 Mar; 191(3):823-830. PubMed ID: 36420948
[TBL] [Abstract][Full Text] [Related]
3. DeSanto-Shinawi Syndrome: First Case in South America.
Vanegas S; Ramirez-Montaño D; Candelo E; Shinawi M; Pachajoa H
Mol Syndromol; 2018 May; 9(3):154-158. PubMed ID: 29928181
[TBL] [Abstract][Full Text] [Related]
4. Congenital heart defects associated with pathogenic variants in WAC gene: Expanding the phenotypic and genotypic spectrum of DeSanto-Shinawi syndrome.
Quental R; Gonçalves D; Rodrigues E; Serrano Gonçalves E; Oliveira J; Parente Freixo J; Leão M
Am J Med Genet A; 2022 Apr; 188(4):1311-1316. PubMed ID: 34997803
[TBL] [Abstract][Full Text] [Related]
5. Three patients with DeSanto-Shinawi syndrome: Further phenotypic delineation.
Uehara T; Ishige T; Hattori S; Yoshihashi H; Funato M; Yamaguchi Y; Takenouchi T; Kosaki K
Am J Med Genet A; 2018 Jun; 176(6):1335-1340. PubMed ID: 29663678
[TBL] [Abstract][Full Text] [Related]
6. Extending the phenotype of DeSanto-Shinawi syndrome: A case report and literature review.
Ho S; Luk HM; Lo IFM
Am J Med Genet A; 2022 Mar; 188(3):984-990. PubMed ID: 34797027
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic comparison of patients affected with DeSanto-Shinawi syndrome: Point mutations in WAC gene versus a 10p12.1 microdeletion including WAC.
Toledo-Gotor C; García-Muro C; García-Oguiza A; Poch-Olivé ML; Ruiz-Del Prado MY; Domínguez-Garrido E
Mol Genet Genomic Med; 2022 May; 10(5):e1910. PubMed ID: 35266333
[TBL] [Abstract][Full Text] [Related]
8. The Phenotypic Spectrum of Desanto-Shinawi Syndrome: A Comparative Report of the First Reported Case in Turkey.
Mail C; Yalcintepe S; Eker D; Gurkan H
Genet Test Mol Biomarkers; 2024 May; 28(5):213-217. PubMed ID: 38613467
[TBL] [Abstract][Full Text] [Related]
9. A Case of DeSanto-Shinawi Syndrome in Bahrain with a Novel Mutation.
Alsahlawi Z; Jailani M; Alaradi H; AlAbbad A
Case Rep Pediatr; 2020; 2020():8820966. PubMed ID: 33123400
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular characterization of five new individuals with WAC-related intellectual disability: Evidence of pathogenicity for a novel splicing variant.
Morales JA; Valenzuela I; Cuscó I; Cogné B; Isidor B; Matalon DR; Gomez-Ospina N
Am J Med Genet A; 2022 May; 188(5):1396-1406. PubMed ID: 35018708
[TBL] [Abstract][Full Text] [Related]
11. Complimentary vertebrate
Lee KH; Stafford AM; Pacheco-Vergara M; Cichewicz K; Canales CP; Seban N; Corea M; Rahbarian D; Bonekamp KE; Gillie GR; Cruz DP; Gill AM; Hwang HE; Uhl KL; Jager TE; Shinawi M; Li X; Obenaus A; Crandall SR; Jeong J; Nord AS; Kim CH; Vogt D
bioRxiv; 2024 May; ():. PubMed ID: 38826421
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and Brain Imaging Findings Associated With a 10p Proximal Deletion Including the WAC Gene: Case Report and Literature Review.
Bolat H; Derin H; Ünsel-Bolat G
Cogn Behav Neurol; 2022 Sep; 35(3):221-226. PubMed ID: 35766809
[TBL] [Abstract][Full Text] [Related]
13. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome.
DeSanto C; D'Aco K; Araujo GC; Shannon N; ; Vernon H; Rahrig A; Monaghan KG; Niu Z; Vitazka P; Dodd J; Tang S; Manwaring L; Martir-Negron A; Schnur RE; Juusola J; Schroeder A; Pan V; Helbig KL; Friedman B; Shinawi M
J Med Genet; 2015 Nov; 52(11):754-61. PubMed ID: 26264232
[TBL] [Abstract][Full Text] [Related]
14. Self-limited focal epilepsy and childhood apraxia of speech with WAC pathogenic variants.
Alawadhi A; Morgan AT; Mucha BE; Scheffer IE; Myers KA
Eur J Paediatr Neurol; 2021 Jan; 30():25-28. PubMed ID: 33387902
[TBL] [Abstract][Full Text] [Related]
15. Structure-Function of the Human WAC Protein in GABAergic Neurons: Towards an Understanding of Autosomal Dominant DeSanto-Shinawi Syndrome.
Rudolph HC; Stafford AM; Hwang HE; Kim CH; Prokop JW; Vogt D
Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106788
[TBL] [Abstract][Full Text] [Related]
16. A de novo 10p11.23-p12.1 deletion recapitulates the phenotype observed in WAC mutations and strengthens the role of WAC in intellectual disability and behavior disorders.
Abdelhedi F; El Khattabi L; Essid N; Viot G; Letessier D; Lebbar A; Dupont JM
Am J Med Genet A; 2016 Jul; 170(7):1912-7. PubMed ID: 27119754
[TBL] [Abstract][Full Text] [Related]
17. De novo loss-of-function mutations in WAC cause a recognizable intellectual disability syndrome and learning deficits in Drosophila.
Lugtenberg D; Reijnders MR; Fenckova M; Bijlsma EK; Bernier R; van Bon BW; Smeets E; Vulto-van Silfhout AT; Bosch D; Eichler EE; Mefford HC; Carvill GL; Bongers EM; Schuurs-Hoeijmakers JH; Ruivenkamp CA; Santen GW; van den Maagdenberg AM; Peeters-Scholte CM; Kuenen S; Verstreken P; Pfundt R; Yntema HG; de Vries PF; Veltman JA; Hoischen A; Gilissen C; de Vries BB; Schenck A; Kleefstra T; Vissers LE
Eur J Hum Genet; 2016 Aug; 24(8):1145-53. PubMed ID: 26757981
[TBL] [Abstract][Full Text] [Related]
18. [WAC gene pathogenic variation cause DeSanto-Shinawi syndrome with electrical status epilepticus during sleep].
Zhang YJ; Yao PL; Zhou YF; Qiu T; Wang J; Wang XH; Zhou SZ; Wu BB; Wang Y
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):802-804. PubMed ID: 31594069
[TBL] [Abstract][Full Text] [Related]
19. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
[TBL] [Abstract][Full Text] [Related]
20. Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism.
Chopra M; McEntagart M; Clayton-Smith J; Platzer K; Shukla A; Girisha KM; Kaur A; Kaur P; Pfundt R; Veenstra-Knol H; Mancini GMS; Cappuccio G; Brunetti-Pierri N; Kortüm F; Hempel M; Denecke J; Lehman A; ; Kleefstra T; Stuurman KE; Wilke M; Thompson ML; Bebin EM; Bijlsma EK; Hoffer MJV; Peeters-Scholte C; Slavotinek A; Weiss WA; Yip T; Hodoglugil U; Whittle A; diMonda J; Neira J; Yang S; Kirby A; Pinz H; Lechner R; Sleutels F; Helbig I; McKeown S; Helbig K; Willaert R; Juusola J; Semotok J; Hadonou M; Short J; ; Yachelevich N; Lala S; Fernández-Jaen A; Pelayo JP; Klöckner C; Kamphausen SB; Abou Jamra R; Arelin M; Innes AM; Niskakoski A; Amin S; Williams M; Evans J; Smithson S; Smedley D; de Burca A; Kini U; Delatycki MB; Gallacher L; Yeung A; Pais L; Field M; Martin E; Charles P; Courtin T; Keren B; Iascone M; Cereda A; Poke G; Abadie V; Chalouhi C; Parthasarathy P; Halliday BJ; Robertson SP; Lyonnet S; Amiel J; Gordon CT
Am J Hum Genet; 2021 Jun; 108(6):1138-1150. PubMed ID: 33909992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
